![4 Things to Know About the End of the COVID-19 PHE](https://www.g2intelligence.com/wp-content/uploads/2023/05/June23.LCA_.EndofPHEandImpactonLaboratories-iStock-1100-x-800-1080x675.jpg)
4 Things to Know About the End of the COVID-19 PHE
The end of the COVID-19 public health emergency on May 11 also brings certain flexibilities for labs and other providers to an end.
The end of the COVID-19 public health emergency on May 11 also brings certain flexibilities for labs and other providers to an end.
New research suggests that the call to rein in low-value prostate cancer screening seems to be falling on deaf ears.
This presentation will highlight some of the management techniques and newer technologies for labs to consider when battling rising expenses.
In this OIG roundup, we cover the agency’s plans to modernize and improve the useability of its Compliance Program Guidance, which was first published in 1998.
A proposed move to make noncompete agreements illegal could impact retention of some laboratory employees.
Last week’s three key cases included two involving drug testing that was either medically unnecessary, or not provided at all.
To avoid claims denials and improper billings, ensure billing and coding staff is aware of, and has adjusted to, all recent coding changes.
CMS recently issued long-awaited guidance on post-PHE changes to Medicare coverage of SARS-CoV-2 diagnostic tests.
While the rule has not yet been approved, if it is, nursing degrees would be considered the equivalent of biological science degrees.
An overview and analysis of the recently proposed changes and how they could affect your medical laboratory.